Balsalazide (Q39446476)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Balsalazide	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

Balsalazide. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Prakash A

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Spencer CM

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

83-9; discussion 90

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal with balsalazide of infertility caused by sulphsalazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salicylates for ulcerative colitis--their mode of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9664201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199856010-00008

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39446476&oldid=2202888303"